These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 33537096)

  • 1. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
    Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
    Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
    [No Abstract]   [Full Text] [Related]  

  • 2. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
    Wu Q; Yang Z; An Y; Hu H; Yin J; Zhang P; Nie Y; Wu K; Shi Y; Fan D
    Cell Death Dis; 2014 Mar; 5(3):e1144. PubMed ID: 24675462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
    Chang H; Zhang X; Li B; Meng X
    Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells.
    Farhana L; Dawson MI; Fontana JA
    Cancer Biol Ther; 2015; 16(1):115-24. PubMed ID: 25611699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
    Salehi-Tabar R; Nguyen-Yamamoto L; Tavera-Mendoza LE; Quail T; Dimitrov V; An BS; Glass L; Goltzman D; White JH
    Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18827-32. PubMed ID: 23112173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
    Anderson DA; Murphy TL; Eisenman RN; Murphy KM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4885-4893. PubMed ID: 32071205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.
    Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S
    Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.
    Zappasodi R; Cavanè A; Iorio MV; Tortoreto M; Guarnotta C; Ruggiero G; Piovan C; Magni M; Zaffaroni N; Tagliabue E; Croce CM; Zunino F; Gianni AM; Di Nicola M
    Int J Cancer; 2014 Nov; 135(9):2034-45. PubMed ID: 24648290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
    Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
    Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.
    Zhang Z; Sun H; Dai H; Walsh RM; Imakura M; Schelter J; Burchard J; Dai X; Chang AN; Diaz RL; Marszalek JR; Bartz SR; Carleton M; Cleary MA; Linsley PS; Grandori C
    Cell Cycle; 2009 Sep; 8(17):2756-68. PubMed ID: 19652553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia.
    Jin J; Li X; Guo W; Li F; Huang J; Huang X; Pan J; Huang S; Ye W; Ling Q; Jin J
    Oncol Rep; 2020 Jul; 44(1):273-282. PubMed ID: 32626988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation.
    Raffeiner P; Hart JR; García-Caballero D; Bar-Peled L; Weinberg MS; Vogt PK
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6571-6579. PubMed ID: 32156728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.
    Hashiguchi T; Bruss N; Best S; Lam V; Danilova O; Paiva CJ; Wolf J; Gilbert EW; Okada CY; Kaur P; Drew L; Cidado J; Hurlin P; Danilov AV
    Mol Cancer Ther; 2019 Sep; 18(9):1520-1532. PubMed ID: 31243099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-9 silencing regulates hTERT expression via β1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.
    Ponnala S; Chetty C; Veeravalli KK; Dinh DH; Klopfenstein JD; Rao JS
    Cell Signal; 2011 Dec; 23(12):2065-75. PubMed ID: 21855630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.
    Zhang X; Zhao H; Zhang Y; Yang X; Zhang J; Yi M; Zhang C
    J Surg Res; 2020 Feb; 246():442-449. PubMed ID: 31635836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.